Adaptive Biotechnologies (ADPT) Research & Development (2018 - 2025)
Historic Research & Development for Adaptive Biotechnologies (ADPT) over the last 8 years, with Q3 2025 value amounting to $23.7 million.
- Adaptive Biotechnologies' Research & Development fell 204.44% to $23.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $95.2 million, marking a year-over-year decrease of 1226.56%. This contributed to the annual value of $103.0 million for FY2024, which is 1569.31% down from last year.
- Latest data reveals that Adaptive Biotechnologies reported Research & Development of $23.7 million as of Q3 2025, which was down 204.44% from $24.1 million recorded in Q2 2025.
- Over the past 5 years, Adaptive Biotechnologies' Research & Development peaked at $37.8 million during Q1 2022, and registered a low of $23.2 million during Q4 2024.
- In the last 5 years, Adaptive Biotechnologies' Research & Development had a median value of $31.2 million in 2022 and averaged $30.6 million.
- As far as peak fluctuations go, Adaptive Biotechnologies' Research & Development skyrocketed by 4542.94% in 2021, and later plummeted by 2135.43% in 2024.
- Quarter analysis of 5 years shows Adaptive Biotechnologies' Research & Development stood at $34.7 million in 2021, then fell by 10.02% to $31.2 million in 2022, then fell by 7.93% to $28.7 million in 2023, then dropped by 19.32% to $23.2 million in 2024, then grew by 2.06% to $23.7 million in 2025.
- Its Research & Development stands at $23.7 million for Q3 2025, versus $24.1 million for Q2 2025 and $24.2 million for Q1 2025.